Research on the Adverse Health Effects of Chemical Weapons on Civilian Survivors: Challenges and Opportunities
Disaster Medicine and Public Health Preparedness · 2025
DOI: 10.1017/dmp.2025.10235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disaster Medicine and Public Health Preparedness, 2025. Verfasst von Faraidoun Moradi. Beteiligte Einrichtung: Centre for Disaster Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Chemical Warfare Agents, Survivors, Chemical Warfare. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Chemical weapons are among the weapons of mass destruction that have caused huge human casualties in the last century. Because of their easy manufacturing and accessibility, and despite international treaties, they remain a serious threat to global security, not just limited to military staff but also to civilian populations and the environment in the short and long term.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Disaster Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, https://ror.org/01tm6cn81University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Faraidoun Moradi
Zitieren
APA
Moradi, F. (2025). Research on the Adverse Health Effects of Chemical Weapons on Civilian Survivors: Challenges and Opportunities. Disaster Medicine and Public Health Preparedness. https://doi.org/10.1017/dmp.2025.10235
Vancouver
Moradi F. Research on the Adverse Health Effects of Chemical Weapons on Civilian Survivors: Challenges and Opportunities. Disaster Medicine and Public Health Preparedness. 2025. doi:10.1017/dmp.2025.10235
BibTeX
@article{Moradi2025,
author = {Moradi, Faraidoun},
title = {Research on the Adverse Health Effects of Chemical Weapons on Civilian Survivors: Challenges and Opportunities},
journal = {Disaster Medicine and Public Health Preparedness},
year = {2025},
doi = {10.1017/dmp.2025.10235}
}
EUVIMED